Review



antibody against hb egf  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Bioss antibody against hb egf
    Antibody Against Hb Egf, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibody+against+hb+egf/HB-EGF+Polyclonal+Antibody/pm35281434-90-15-21
    Average 92 stars, based on 9 article reviews
    antibody against hb egf - by Bioz Stars, 2026-10
    92/100 stars

    Images

    Related Articles

    Molecular Weight:

    Article Title: HB-EGF Plays a Pivotal Role in Mucosal Hyperplasia During Otitis Media Induced by a Viral Analog
    Article Snippet: Proteins were electrotransferred to polyvinylidene difluoride membranes (PVDF) (Bio-Rad). .. PVDF membranes were probed with anti-β-actin antibody (mouse monoclonal, 1:10000, BD Transduction Laboratories) and the antibody against HB-EGF (rabbit, polyclonal, 1:3000, Bioss) that recognizes both forms of the factor, with which sHB-EGF can be distinguished from proHB-EGF (18.7 kDa) by its lower molecular weight (9.7 kDa). .. Membranes were incubated with horseradish peroxidase-conjugated secondary antibodies (anti-mouse antibody for β-actin, 1:20000) (anti-rabbit antibody for HB-EGF, 1:10000) and visualized with chemiluminescent detection (GE Healthcare).

    Article Title: HB-EGF Plays a Pivotal Role in Mucosal Hyperplasia During Otitis Media Induced by a Viral Analog.
    Article Snippet: Proteins were electrotransferred to polyvinylidene difluoride membranes (PVDF) (Bio-Rad). .. PVDF membranes were probed with anti-b-actin antibody (mouse monoclonal, 1:10000, BD Transduction Laboratories) and the antibody against HB-EGF (rabbit, polyclonal, 1:3000, Bioss) that recognizes both forms of the factor, with which sHB-EGF can be distinguished fromproHBEGF (18.7 kDa) by its lower molecular weight (9.7 kDa). .. Membranes were incubated with horseradish peroxidaseconjugated secondary antibodies (anti-mouse antibody for bactin, 1:20000) (anti-rabbit antibody for HB-EGF, 1:10000) and visualizedwith chemiluminescent detection (GEHealthcare).



    Similar Products

    92
    Bioss antibody against hb egf
    Antibody Against Hb Egf, supplied by Bioss, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibody+against+hb+egf/HB-EGF+Polyclonal+Antibody/pm35281434-90-15-21
    Average 92 stars, based on 1 article reviews
    antibody against hb egf - by Bioz Stars, 2026-10
    92/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology antibodies against hb egf
    Antibodies Against Hb Egf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibody+against+hb+egf/HB-EGF+Antibody/pm40247713-70-24-28
    Average 93 stars, based on 1 article reviews
    antibodies against hb egf - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology monoclonal antibodies against human hb egf
    Monoclonal Antibodies Against Human Hb Egf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibody+against+hb+egf/HB-EGF+Antibody/pm39631139-47-1-10
    Average 93 stars, based on 1 article reviews
    monoclonal antibodies against human hb egf - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology primary antibody against hb egf
    Figure 1. Expression of <t>HB-EGF</t> is decreased under diabetic conditions. (A) Double-immunofluorescence staining of PECAM-1/HB-EGF (top panel) and NG2/HB-EGF (bottom panel) in penile tissues of age-matched control and diabetic mice. Nuclei were stained with DAPI (blue). Scale bar, 100 μm. (B) Representative Western blots for PECAM-1, NG2, and HB-EGF in corpus cavernosum tissue from age-matched control and diabetic mice. (C) Representative Western blots for HB-EGF in MCECs, and MCPs exposed to NG and HG conditions. (D-F) Normalized areas of PECAM-1, NG2, and HB-EGF–immunopositive staining were quantified using ImageJ software (n = 4). (G-K) Normalized band intensity values for indicated targets were quantified using ImageJ software (n = 4). Results are presented as mean ± SEM. ∗∗P < .01; ∗∗∗P < .001. The relative ratio of the control or NG group was arbitrarily set to 1. DAPI, 4′,6-diamidino-2-phenylindole; DM, diabetes mellitus; HB-EGF, heparin-binding epidermal growth factor–like growth factor; HG, high glucose; MCEC, mouse cavernous endothelial cell; MCP, mouse cavernous pericyte; NG, normal glucose; PECAM-1, platelet/endothelial adhesion molecule 1.
    Primary Antibody Against Hb Egf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibody+against+hb+egf/HB-EGF+Antibody/pm39033084-74-55-60
    Average 93 stars, based on 1 article reviews
    primary antibody against hb egf - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc antibodies against hb egf
    Fig. 3 <t>HB-EGF</t> was directly targeted by miR-194. A Venn diagram demonstrates the intersection of data extracted from several bioinformatics websites. (B) Binding sites shared between miR-194 and HB-EGF. (C-D) HB-EGF protein and mRNA expression in the GCs. KGN cells were transfected for 48 h with miR-194 mimic, miR-194 inhibitor, or the miR-NC group. (E) Luciferase reporter assays. (F) miR-194 and HB-EGF mRNA expression in PCOS patient ovarian GCs. n= 3-6 for each group; *P < 0.05 vs. control group or miR-NC group
    Antibodies Against Hb Egf, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibody+against+hb+egf/pm34814928-83-17-23
    Average 86 stars, based on 1 article reviews
    antibodies against hb egf - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    90
    ABclonal Biotechnology antibodies against hb-egf
    Fig. 3 <t>HB-EGF</t> was directly targeted by miR-194. A Venn diagram demonstrates the intersection of data extracted from several bioinformatics websites. (B) Binding sites shared between miR-194 and HB-EGF. (C-D) HB-EGF protein and mRNA expression in the GCs. KGN cells were transfected for 48 h with miR-194 mimic, miR-194 inhibitor, or the miR-NC group. (E) Luciferase reporter assays. (F) miR-194 and HB-EGF mRNA expression in PCOS patient ovarian GCs. n= 3-6 for each group; *P < 0.05 vs. control group or miR-NC group
    Antibodies Against Hb Egf, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/antibody+against+hb+egf/antibodies+against+hb+egf/pmc08763942-275-0-12
    Average 90 stars, based on 1 article reviews
    antibodies against hb-egf - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Figure 1. Expression of HB-EGF is decreased under diabetic conditions. (A) Double-immunofluorescence staining of PECAM-1/HB-EGF (top panel) and NG2/HB-EGF (bottom panel) in penile tissues of age-matched control and diabetic mice. Nuclei were stained with DAPI (blue). Scale bar, 100 μm. (B) Representative Western blots for PECAM-1, NG2, and HB-EGF in corpus cavernosum tissue from age-matched control and diabetic mice. (C) Representative Western blots for HB-EGF in MCECs, and MCPs exposed to NG and HG conditions. (D-F) Normalized areas of PECAM-1, NG2, and HB-EGF–immunopositive staining were quantified using ImageJ software (n = 4). (G-K) Normalized band intensity values for indicated targets were quantified using ImageJ software (n = 4). Results are presented as mean ± SEM. ∗∗P < .01; ∗∗∗P < .001. The relative ratio of the control or NG group was arbitrarily set to 1. DAPI, 4′,6-diamidino-2-phenylindole; DM, diabetes mellitus; HB-EGF, heparin-binding epidermal growth factor–like growth factor; HG, high glucose; MCEC, mouse cavernous endothelial cell; MCP, mouse cavernous pericyte; NG, normal glucose; PECAM-1, platelet/endothelial adhesion molecule 1.

    Journal: The journal of sexual medicine

    Article Title: Heparin-binding epidermal growth factor-like growth factor improves erectile function in streptozotocin-induced diabetic mice.

    doi: 10.1093/jsxmed/qdae079

    Figure Lengend Snippet: Figure 1. Expression of HB-EGF is decreased under diabetic conditions. (A) Double-immunofluorescence staining of PECAM-1/HB-EGF (top panel) and NG2/HB-EGF (bottom panel) in penile tissues of age-matched control and diabetic mice. Nuclei were stained with DAPI (blue). Scale bar, 100 μm. (B) Representative Western blots for PECAM-1, NG2, and HB-EGF in corpus cavernosum tissue from age-matched control and diabetic mice. (C) Representative Western blots for HB-EGF in MCECs, and MCPs exposed to NG and HG conditions. (D-F) Normalized areas of PECAM-1, NG2, and HB-EGF–immunopositive staining were quantified using ImageJ software (n = 4). (G-K) Normalized band intensity values for indicated targets were quantified using ImageJ software (n = 4). Results are presented as mean ± SEM. ∗∗P < .01; ∗∗∗P < .001. The relative ratio of the control or NG group was arbitrarily set to 1. DAPI, 4′,6-diamidino-2-phenylindole; DM, diabetes mellitus; HB-EGF, heparin-binding epidermal growth factor–like growth factor; HG, high glucose; MCEC, mouse cavernous endothelial cell; MCP, mouse cavernous pericyte; NG, normal glucose; PECAM-1, platelet/endothelial adhesion molecule 1.

    Article Snippet: For immunofluorescence analysis, penis tissues were fixed in 4% paraformaldehyde at 4◦C for 24 hours, and cell samples were fixed in 4% paraformaldehyde at 4◦C for 15 minutes at room temperature, as described previously.21 Frozen tissue sections (12 μm thick), MCECs, and MCPs were washed and then incubated overnight at 4◦C with the following antibodies: primary antibody against HB-EGF (1:100, Santa Cruz Biotechnology Inc., Dallas, TX, United States), platelet/endothelial adhesion molecule 1 (PECAM1; 1:100; Millipore, Temecula, CA, United States), NG2 (1:50; Millipore), phosphohistone H3 (1:50; Millipore), neuronal NOS (nNOS; 1:100; Santa Cruz Biotechnology Inc.), neurofilament (1:50; Sigma-Aldrich), occludin (1:100; Novus Biologicals, Littleton, CO, United States), claudin-5 (1:100; Invitrogen, Carlsbad, CA, United States), oxidized low-density lipoprotein (Ox-LDL: 1:100; Abcam, Cambridge, MA, United States), and phospho-eNOS (1:50; Invitrogen).

    Techniques: Expressing, Staining, Control, Western Blot, Software, Binding Assay

    Figure 2. HB-EGF promotes angiogenesis and proliferation under HG conditions. (A) Tube formation assays of MCECs treated with PBS or HB-EGF (50, 100, 200, or 500 ng/mL) under normal-glucose (NG) and high-glucose (HG) conditions. Scale bar = 100 μm. (B and C) Migration assays in MCECs and MCPs treated with PBS or HB-EGF (100 ng/mL) under NG or HG conditions. Scale bar = 100 μm. (D) Representative images of immunofluorescent staining of PH3 (red and green) in MCECs and MCPs treated with PBS or HB-EGF (100 ng/mL) under NG or HG conditions. Nuclei were stained with DAPI (blue). Scale bar, 50 μm. (F) The number of master junctions in MCECs was quantified using ImageJ software (n = 4). (G and H) The number of migrated MCECs (G) and MCPs (H) within the frame line was quantified using ImageJ software (n = 4). (I and J) The number of PH3-positive MCECs (I) and MCPs (J) was quantified using ImageJ software (n = 4). Results are presented as mean ± SEM. ∗∗P < .01; ∗∗∗P < .001. The relative ratio of the NG (G-J) group was arbitrarily set to 1. DAPI, 4′,6-diamidino-2-phenylindole; HB-EGF, heparin-binding epidermal growth factor–like growth factor; HG, high glucose; MCEC, mouse cavernous endothelial cell; MCP, mouse cavernous pericyte; NG, normal glucose; PBS, phosphate-buffered saline; PH3, phosphohistone H3.

    Journal: The journal of sexual medicine

    Article Title: Heparin-binding epidermal growth factor-like growth factor improves erectile function in streptozotocin-induced diabetic mice.

    doi: 10.1093/jsxmed/qdae079

    Figure Lengend Snippet: Figure 2. HB-EGF promotes angiogenesis and proliferation under HG conditions. (A) Tube formation assays of MCECs treated with PBS or HB-EGF (50, 100, 200, or 500 ng/mL) under normal-glucose (NG) and high-glucose (HG) conditions. Scale bar = 100 μm. (B and C) Migration assays in MCECs and MCPs treated with PBS or HB-EGF (100 ng/mL) under NG or HG conditions. Scale bar = 100 μm. (D) Representative images of immunofluorescent staining of PH3 (red and green) in MCECs and MCPs treated with PBS or HB-EGF (100 ng/mL) under NG or HG conditions. Nuclei were stained with DAPI (blue). Scale bar, 50 μm. (F) The number of master junctions in MCECs was quantified using ImageJ software (n = 4). (G and H) The number of migrated MCECs (G) and MCPs (H) within the frame line was quantified using ImageJ software (n = 4). (I and J) The number of PH3-positive MCECs (I) and MCPs (J) was quantified using ImageJ software (n = 4). Results are presented as mean ± SEM. ∗∗P < .01; ∗∗∗P < .001. The relative ratio of the NG (G-J) group was arbitrarily set to 1. DAPI, 4′,6-diamidino-2-phenylindole; HB-EGF, heparin-binding epidermal growth factor–like growth factor; HG, high glucose; MCEC, mouse cavernous endothelial cell; MCP, mouse cavernous pericyte; NG, normal glucose; PBS, phosphate-buffered saline; PH3, phosphohistone H3.

    Article Snippet: For immunofluorescence analysis, penis tissues were fixed in 4% paraformaldehyde at 4◦C for 24 hours, and cell samples were fixed in 4% paraformaldehyde at 4◦C for 15 minutes at room temperature, as described previously.21 Frozen tissue sections (12 μm thick), MCECs, and MCPs were washed and then incubated overnight at 4◦C with the following antibodies: primary antibody against HB-EGF (1:100, Santa Cruz Biotechnology Inc., Dallas, TX, United States), platelet/endothelial adhesion molecule 1 (PECAM1; 1:100; Millipore, Temecula, CA, United States), NG2 (1:50; Millipore), phosphohistone H3 (1:50; Millipore), neuronal NOS (nNOS; 1:100; Santa Cruz Biotechnology Inc.), neurofilament (1:50; Sigma-Aldrich), occludin (1:100; Novus Biologicals, Littleton, CO, United States), claudin-5 (1:100; Invitrogen, Carlsbad, CA, United States), oxidized low-density lipoprotein (Ox-LDL: 1:100; Abcam, Cambridge, MA, United States), and phospho-eNOS (1:50; Invitrogen).

    Techniques: Migration, Staining, Software, Binding Assay, Saline

    Figure 3. HB-EGF improves erectile function in STZ-induced diabetic mice. (A) Representative ICP responses in age-matched control and diabetic mice 2 weeks after 2 intracavernous administrations of PBS or various doses of HB-EGF (days −3 and 0; 1 μg, 5 μg, and 10 μg in 20 μL of PBS, respectively). The solid bar indicates the stimulus interval. (B and C) ratios of maximum ICP (B) and total ICP (C) to MSBP were calculated for each group (n = 10). Results are presented as mean ± SEM. ∗P < .05; ∗∗P < .01; ∗∗∗P < .001. HB-EGF, heparin-binding epidermal growth factor–like growth factor; ICP, intracavernous pressure; MSBP, mean systolic blood pressure; PBS, phosphate-buffered saline; STZ, streptozotocin.

    Journal: The journal of sexual medicine

    Article Title: Heparin-binding epidermal growth factor-like growth factor improves erectile function in streptozotocin-induced diabetic mice.

    doi: 10.1093/jsxmed/qdae079

    Figure Lengend Snippet: Figure 3. HB-EGF improves erectile function in STZ-induced diabetic mice. (A) Representative ICP responses in age-matched control and diabetic mice 2 weeks after 2 intracavernous administrations of PBS or various doses of HB-EGF (days −3 and 0; 1 μg, 5 μg, and 10 μg in 20 μL of PBS, respectively). The solid bar indicates the stimulus interval. (B and C) ratios of maximum ICP (B) and total ICP (C) to MSBP were calculated for each group (n = 10). Results are presented as mean ± SEM. ∗P < .05; ∗∗P < .01; ∗∗∗P < .001. HB-EGF, heparin-binding epidermal growth factor–like growth factor; ICP, intracavernous pressure; MSBP, mean systolic blood pressure; PBS, phosphate-buffered saline; STZ, streptozotocin.

    Article Snippet: For immunofluorescence analysis, penis tissues were fixed in 4% paraformaldehyde at 4◦C for 24 hours, and cell samples were fixed in 4% paraformaldehyde at 4◦C for 15 minutes at room temperature, as described previously.21 Frozen tissue sections (12 μm thick), MCECs, and MCPs were washed and then incubated overnight at 4◦C with the following antibodies: primary antibody against HB-EGF (1:100, Santa Cruz Biotechnology Inc., Dallas, TX, United States), platelet/endothelial adhesion molecule 1 (PECAM1; 1:100; Millipore, Temecula, CA, United States), NG2 (1:50; Millipore), phosphohistone H3 (1:50; Millipore), neuronal NOS (nNOS; 1:100; Santa Cruz Biotechnology Inc.), neurofilament (1:50; Sigma-Aldrich), occludin (1:100; Novus Biologicals, Littleton, CO, United States), claudin-5 (1:100; Invitrogen, Carlsbad, CA, United States), oxidized low-density lipoprotein (Ox-LDL: 1:100; Abcam, Cambridge, MA, United States), and phospho-eNOS (1:50; Invitrogen).

    Techniques: Control, Binding Assay, Saline

    Figure 4. HB-EGF increases cavernous endothelial cell, pericyte, and neuronal cell content in STZ-induced diabetic mice. (A and B) double-immunofluorescence staining of PECAM-1/NG2 (A) and nNOS/NF (B) in penile tissues from age-matched control and diabetic mice 2 weeks after two intracavernous administrations of PBS or HB-EGF (days −3 and 0; 5 μg in 20 μL of PBS). Nuclei were stained with DAPI (blue). Scale bar, 100 μm (A) or 25 μm (B). (C-F) quantification of PECAM-1, NG2, nNOS, and NF immunopositive areas using ImageJ software (n = 4). (G) Representative Western blots for PECAM-1, NG2, and nNOS in penile tissues from age-matched control and diabetic mice 2 weeks after two intracavernous administrations of PBS or HB-EGF (days −3 and 0; 5 μg in 20 μL of PBS). (H-J) normalized band intensity values for indicated targets were quantified using ImageJ software (n = 4). Results are presented as mean ± SEM. ∗∗P < .01; ∗∗∗P < .001. The relative ratio of the control group was arbitrarily set to 1. DAPI, 4′,6-diamidino-2-phenylindole; PECAM-1, platelet/endothelial adhesion molecule 1; HB-EGF, heparin-binding epidermal growth factor–like growth factor; NG2, nerve/glial-antigen 2; STZ, streptozotocin.

    Journal: The journal of sexual medicine

    Article Title: Heparin-binding epidermal growth factor-like growth factor improves erectile function in streptozotocin-induced diabetic mice.

    doi: 10.1093/jsxmed/qdae079

    Figure Lengend Snippet: Figure 4. HB-EGF increases cavernous endothelial cell, pericyte, and neuronal cell content in STZ-induced diabetic mice. (A and B) double-immunofluorescence staining of PECAM-1/NG2 (A) and nNOS/NF (B) in penile tissues from age-matched control and diabetic mice 2 weeks after two intracavernous administrations of PBS or HB-EGF (days −3 and 0; 5 μg in 20 μL of PBS). Nuclei were stained with DAPI (blue). Scale bar, 100 μm (A) or 25 μm (B). (C-F) quantification of PECAM-1, NG2, nNOS, and NF immunopositive areas using ImageJ software (n = 4). (G) Representative Western blots for PECAM-1, NG2, and nNOS in penile tissues from age-matched control and diabetic mice 2 weeks after two intracavernous administrations of PBS or HB-EGF (days −3 and 0; 5 μg in 20 μL of PBS). (H-J) normalized band intensity values for indicated targets were quantified using ImageJ software (n = 4). Results are presented as mean ± SEM. ∗∗P < .01; ∗∗∗P < .001. The relative ratio of the control group was arbitrarily set to 1. DAPI, 4′,6-diamidino-2-phenylindole; PECAM-1, platelet/endothelial adhesion molecule 1; HB-EGF, heparin-binding epidermal growth factor–like growth factor; NG2, nerve/glial-antigen 2; STZ, streptozotocin.

    Article Snippet: For immunofluorescence analysis, penis tissues were fixed in 4% paraformaldehyde at 4◦C for 24 hours, and cell samples were fixed in 4% paraformaldehyde at 4◦C for 15 minutes at room temperature, as described previously.21 Frozen tissue sections (12 μm thick), MCECs, and MCPs were washed and then incubated overnight at 4◦C with the following antibodies: primary antibody against HB-EGF (1:100, Santa Cruz Biotechnology Inc., Dallas, TX, United States), platelet/endothelial adhesion molecule 1 (PECAM1; 1:100; Millipore, Temecula, CA, United States), NG2 (1:50; Millipore), phosphohistone H3 (1:50; Millipore), neuronal NOS (nNOS; 1:100; Santa Cruz Biotechnology Inc.), neurofilament (1:50; Sigma-Aldrich), occludin (1:100; Novus Biologicals, Littleton, CO, United States), claudin-5 (1:100; Invitrogen, Carlsbad, CA, United States), oxidized low-density lipoprotein (Ox-LDL: 1:100; Abcam, Cambridge, MA, United States), and phospho-eNOS (1:50; Invitrogen).

    Techniques: Staining, Control, Software, Western Blot, Binding Assay

    Figure 5. HB-EGF induces tight junction protein levels and reduces permeability in STZ-induced diabetic mice. (A) Double-immunofluorescence staining of occludin (green) and claudin-5 (red) in penile tissues from age-matched control and diabetic mice 2 weeks after two intracavernous administrations of PBS or HB-EGF (days −3 and 0; 5 μg in 20 μL of PBS). (B) Ox-LDL (green) staining in the same samples. Nuclei labeled with DAPI (blue). Scale bar, 100 μm. (C-E) quantitative analysis of occludin, claudin, and ox-LDL immunopositive areas using ImageJ software (n = 4). (F) Representative Western blots for Occludin and Claudin-5 in penile tissues from age-matched control and diabetic mice 2 weeks after two intracavernous administrations of PBS or HB-EGF (days −3 and 0; 5 μg in 20 μL of PBS). (G and H) normalized band intensity values for indicated targets were quantified using ImageJ software (n = 4). Results are presented as mean ± SEM. ∗∗P < .01; ∗∗∗P < .001. The relative ratio of the control group was arbitrarily set to 1. DAPI, 4′,6-diamidino-2-phenylindole; DM, diabetes mellitus; HB-EGF, heparin-binding epidermal growth factor–like growth factor; ox-LDL, oxidized low-density lipoprotein; STZ, streptozotocin.

    Journal: The journal of sexual medicine

    Article Title: Heparin-binding epidermal growth factor-like growth factor improves erectile function in streptozotocin-induced diabetic mice.

    doi: 10.1093/jsxmed/qdae079

    Figure Lengend Snippet: Figure 5. HB-EGF induces tight junction protein levels and reduces permeability in STZ-induced diabetic mice. (A) Double-immunofluorescence staining of occludin (green) and claudin-5 (red) in penile tissues from age-matched control and diabetic mice 2 weeks after two intracavernous administrations of PBS or HB-EGF (days −3 and 0; 5 μg in 20 μL of PBS). (B) Ox-LDL (green) staining in the same samples. Nuclei labeled with DAPI (blue). Scale bar, 100 μm. (C-E) quantitative analysis of occludin, claudin, and ox-LDL immunopositive areas using ImageJ software (n = 4). (F) Representative Western blots for Occludin and Claudin-5 in penile tissues from age-matched control and diabetic mice 2 weeks after two intracavernous administrations of PBS or HB-EGF (days −3 and 0; 5 μg in 20 μL of PBS). (G and H) normalized band intensity values for indicated targets were quantified using ImageJ software (n = 4). Results are presented as mean ± SEM. ∗∗P < .01; ∗∗∗P < .001. The relative ratio of the control group was arbitrarily set to 1. DAPI, 4′,6-diamidino-2-phenylindole; DM, diabetes mellitus; HB-EGF, heparin-binding epidermal growth factor–like growth factor; ox-LDL, oxidized low-density lipoprotein; STZ, streptozotocin.

    Article Snippet: For immunofluorescence analysis, penis tissues were fixed in 4% paraformaldehyde at 4◦C for 24 hours, and cell samples were fixed in 4% paraformaldehyde at 4◦C for 15 minutes at room temperature, as described previously.21 Frozen tissue sections (12 μm thick), MCECs, and MCPs were washed and then incubated overnight at 4◦C with the following antibodies: primary antibody against HB-EGF (1:100, Santa Cruz Biotechnology Inc., Dallas, TX, United States), platelet/endothelial adhesion molecule 1 (PECAM1; 1:100; Millipore, Temecula, CA, United States), NG2 (1:50; Millipore), phosphohistone H3 (1:50; Millipore), neuronal NOS (nNOS; 1:100; Santa Cruz Biotechnology Inc.), neurofilament (1:50; Sigma-Aldrich), occludin (1:100; Novus Biologicals, Littleton, CO, United States), claudin-5 (1:100; Invitrogen, Carlsbad, CA, United States), oxidized low-density lipoprotein (Ox-LDL: 1:100; Abcam, Cambridge, MA, United States), and phospho-eNOS (1:50; Invitrogen).

    Techniques: Permeability, Staining, Control, Labeling, Software, Western Blot, Binding Assay

    Figure 6. HB-EGF activates the AKT/eNOS signaling pathway in STZ-induced diabetic mice. (A) Representative Western blots for p-AKTSer473, total AKT, p-eNOSSer1177, and total eNOS in penile tissues from age-matched control and diabetic mice 2 weeks after two intracavernous administrations of PBS or HB-EGF (days −3 and 0; 5 μg in 20 μL of PBS). (B and C) normalized band intensity values for indicated targets were quantified using ImageJ software (n = 4). (D) Double-immunofluorescence staining of occludin (green) and claudin-5 (red) in penile tissues after ICP study. (E) Quantitative analysis of p-eNOSSer1177 immunopositive areas using ImageJ software (n = 4). Results are presented as mean ± SEM. ∗P < .05; ∗∗P < .01; ∗∗∗P < .001. The relative ratio of the control group was arbitrarily set to 1. DAPI, 4′,6-diamidino-2-phenylindole; eNos, endothelial nitric oxide synthase; HB-EGF, heparin-binding epidermal growth factor–like growth factor; ICP, intracavernous pressure; PBS, phosphate-buffered saline; p-eNOS, phosphorylated endothelial nitric oxide synthase; STZ, streptozotocin.

    Journal: The journal of sexual medicine

    Article Title: Heparin-binding epidermal growth factor-like growth factor improves erectile function in streptozotocin-induced diabetic mice.

    doi: 10.1093/jsxmed/qdae079

    Figure Lengend Snippet: Figure 6. HB-EGF activates the AKT/eNOS signaling pathway in STZ-induced diabetic mice. (A) Representative Western blots for p-AKTSer473, total AKT, p-eNOSSer1177, and total eNOS in penile tissues from age-matched control and diabetic mice 2 weeks after two intracavernous administrations of PBS or HB-EGF (days −3 and 0; 5 μg in 20 μL of PBS). (B and C) normalized band intensity values for indicated targets were quantified using ImageJ software (n = 4). (D) Double-immunofluorescence staining of occludin (green) and claudin-5 (red) in penile tissues after ICP study. (E) Quantitative analysis of p-eNOSSer1177 immunopositive areas using ImageJ software (n = 4). Results are presented as mean ± SEM. ∗P < .05; ∗∗P < .01; ∗∗∗P < .001. The relative ratio of the control group was arbitrarily set to 1. DAPI, 4′,6-diamidino-2-phenylindole; eNos, endothelial nitric oxide synthase; HB-EGF, heparin-binding epidermal growth factor–like growth factor; ICP, intracavernous pressure; PBS, phosphate-buffered saline; p-eNOS, phosphorylated endothelial nitric oxide synthase; STZ, streptozotocin.

    Article Snippet: For immunofluorescence analysis, penis tissues were fixed in 4% paraformaldehyde at 4◦C for 24 hours, and cell samples were fixed in 4% paraformaldehyde at 4◦C for 15 minutes at room temperature, as described previously.21 Frozen tissue sections (12 μm thick), MCECs, and MCPs were washed and then incubated overnight at 4◦C with the following antibodies: primary antibody against HB-EGF (1:100, Santa Cruz Biotechnology Inc., Dallas, TX, United States), platelet/endothelial adhesion molecule 1 (PECAM1; 1:100; Millipore, Temecula, CA, United States), NG2 (1:50; Millipore), phosphohistone H3 (1:50; Millipore), neuronal NOS (nNOS; 1:100; Santa Cruz Biotechnology Inc.), neurofilament (1:50; Sigma-Aldrich), occludin (1:100; Novus Biologicals, Littleton, CO, United States), claudin-5 (1:100; Invitrogen, Carlsbad, CA, United States), oxidized low-density lipoprotein (Ox-LDL: 1:100; Abcam, Cambridge, MA, United States), and phospho-eNOS (1:50; Invitrogen).

    Techniques: Western Blot, Control, Software, Staining, Binding Assay, Saline

    Fig. 3 HB-EGF was directly targeted by miR-194. A Venn diagram demonstrates the intersection of data extracted from several bioinformatics websites. (B) Binding sites shared between miR-194 and HB-EGF. (C-D) HB-EGF protein and mRNA expression in the GCs. KGN cells were transfected for 48 h with miR-194 mimic, miR-194 inhibitor, or the miR-NC group. (E) Luciferase reporter assays. (F) miR-194 and HB-EGF mRNA expression in PCOS patient ovarian GCs. n= 3-6 for each group; *P < 0.05 vs. control group or miR-NC group

    Journal: Reproductive biology and endocrinology : RB&E

    Article Title: microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor.

    doi: 10.1186/s12958-021-00850-w

    Figure Lengend Snippet: Fig. 3 HB-EGF was directly targeted by miR-194. A Venn diagram demonstrates the intersection of data extracted from several bioinformatics websites. (B) Binding sites shared between miR-194 and HB-EGF. (C-D) HB-EGF protein and mRNA expression in the GCs. KGN cells were transfected for 48 h with miR-194 mimic, miR-194 inhibitor, or the miR-NC group. (E) Luciferase reporter assays. (F) miR-194 and HB-EGF mRNA expression in PCOS patient ovarian GCs. n= 3-6 for each group; *P < 0.05 vs. control group or miR-NC group

    Article Snippet: Non-fat milk was used to treat membranes for 2 h at 4 °C before probing overnight with antibodies against HB-EGF (catalog # 15,071; Cell Signaling Technology, USA), p53 (catalog # wL01919; Wanleigio), p21 (catalog # WLH0362; Wanleigio), p16 (catalog # WLH3673; Wanleigio) and β-actin (catalog # 3700; Cell Signaling Technology).

    Techniques: Binding Assay, Expressing, Transfection, Luciferase, Control

    Fig. 4 HB-EGF was decreased in ovarian tissues from PCOS rat model and PCOS GCs. (A) Western blotting and (B) qRT-PCR were used to quantify HB-EGF protein and mRNA levels in the PCOS rat model. (C) qRT-PCR demonstrate HB-EGF mRNA expression in PCOS patient GCs and the control group (n=10). B-C. 𝑛 = 3-6 for each group. *P < 0.05 vs. control group

    Journal: Reproductive biology and endocrinology : RB&E

    Article Title: microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor.

    doi: 10.1186/s12958-021-00850-w

    Figure Lengend Snippet: Fig. 4 HB-EGF was decreased in ovarian tissues from PCOS rat model and PCOS GCs. (A) Western blotting and (B) qRT-PCR were used to quantify HB-EGF protein and mRNA levels in the PCOS rat model. (C) qRT-PCR demonstrate HB-EGF mRNA expression in PCOS patient GCs and the control group (n=10). B-C. 𝑛 = 3-6 for each group. *P < 0.05 vs. control group

    Article Snippet: Non-fat milk was used to treat membranes for 2 h at 4 °C before probing overnight with antibodies against HB-EGF (catalog # 15,071; Cell Signaling Technology, USA), p53 (catalog # wL01919; Wanleigio), p21 (catalog # WLH0362; Wanleigio), p16 (catalog # WLH3673; Wanleigio) and β-actin (catalog # 3700; Cell Signaling Technology).

    Techniques: Western Blot, Quantitative RT-PCR, Expressing, Control

    Fig. 5 Upregulated HB-EGF reverses the effect of miR-194 mimic in KGN cells growth and apoptosis. (A) The expression of HB-EGF in KGN cells post-transfection with HB-EGF-OE. (B) The expression of HB-EGF in KGN cells post transfection with miR-194 mimic or miR-194 mimic+HB-EGF-OE. (C-D) The apoptotic rate of KGN cells was determined using AO/EB and flow cytometry. 𝑛 = 3-6 for each group; *P < 0.05 vs. miR-NC mimic group

    Journal: Reproductive biology and endocrinology : RB&E

    Article Title: microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor.

    doi: 10.1186/s12958-021-00850-w

    Figure Lengend Snippet: Fig. 5 Upregulated HB-EGF reverses the effect of miR-194 mimic in KGN cells growth and apoptosis. (A) The expression of HB-EGF in KGN cells post-transfection with HB-EGF-OE. (B) The expression of HB-EGF in KGN cells post transfection with miR-194 mimic or miR-194 mimic+HB-EGF-OE. (C-D) The apoptotic rate of KGN cells was determined using AO/EB and flow cytometry. 𝑛 = 3-6 for each group; *P < 0.05 vs. miR-NC mimic group

    Article Snippet: Non-fat milk was used to treat membranes for 2 h at 4 °C before probing overnight with antibodies against HB-EGF (catalog # 15,071; Cell Signaling Technology, USA), p53 (catalog # wL01919; Wanleigio), p21 (catalog # WLH0362; Wanleigio), p16 (catalog # WLH3673; Wanleigio) and β-actin (catalog # 3700; Cell Signaling Technology).

    Techniques: Expressing, Transfection, Flow Cytometry